TrialThe oncologist2019

Docetaxel, Oxaliplatin, and 5-Fluorouracil (DOF) in Metastatic and Unresectable Gastric/Gastroesophageal Junction Adenocarcinoma: A Phase II Study with Long-Term Follow-Up.

Ari Joseph Rosenberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.